Scientists are discovering a "strange" way to eliminate cancer

health Hassan ali

Scientists are discovering a "strange" way to eliminate cancer

LONDON (Reuters) - Scientists at the University of Surrey have discovered what could be a "breakthrough" in the fight against cancer, where they discovered a strain of the common cold virus had destroyed cancerous tumors.
↛

In a university experiment involving patients in the early stages of cancer, scientists succeeded in using the "Coxsaki" virus, a strain of the common cold virus, which injected it into patients' cysts.

↚

A week later, researchers found that this cold virus successfully targeted cancer cells and caused their destruction and death, according to the newspaper "Daily Star" British.

According to documents summarizing the medical experiment published in the Journal of Clinical Cancer Research, the disease disappeared completely in a patient who had bladder cancer, and showed no trace of the disease after the innovative treatment.

In addition, there were no side effects in any of the patients, not to mention that the healthy cells around the tumors remained unchanged and was not affected by the treatment targeted only cancer cells, knowing that most of the treatments available to cancer patients currently can cause serious side effects.

↮

"The method of treatment works by heating the tumor and recruiting all the immune cells in the right place," said University of Pennsylvania professor of research Prof. Hardev Panda.

↚

Hardiff said the findings were surprising to researchers who expressed the hope that this breakthrough would "revolutionize the treatment" of the deadly disease.

A bladder cancer charity described the study as "very exciting", especially if other, larger studies confirmed the findings.

"If it is possible to confirm the safety data and the various possibilities and the effectiveness of this procedure through further studies and clinical trials, it can promise a new era in the treatment of bladder cancer," said Alan Knight, chairman of the British Cancer Society.

The UK Cancer Research Center said the findings were "encouraging".